Yeast as a model system for anticancer drug discovery
- 1 June 2004
- journal article
- Published by Springer Science and Business Media LLC in Nature Reviews Cancer
- Vol. 4 (6), 481-487
- https://doi.org/10.1038/nrc1372
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathwaysNature Biotechnology, 2003
- Targets of the cyclin-dependent kinase Cdk1Nature, 2003
- NAD+-Dependent Deacetylase Hst1p Controls Biosynthesis and Cellular NAD+ Levels in Saccharomyces cerevisiaeMolecular and Cellular Biology, 2003
- In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expressionBlood, 2003
- Acetylation inactivates the transcriptional repressor BCL6Nature Genetics, 2002
- Comparative assessment of large-scale data sets of protein–protein interactionsNature, 2002
- Acute Myeloid Leukemia with inv(8)(p11q13)Leukemia & Lymphoma, 2000
- Drug target validation and identification of secondary drug target effects using DNA microarraysNature Medicine, 1998
- Targeted mutation of the DNA methyltransferase gene results in embryonic lethalityCell, 1992
- S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule functionCell, 1991